DRNA
Dicerna Pharmaceuticals Inc
Price:  
38.22 
USD
Volume:  
5,675,031.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DRNA Relative Valuation

-229.4%
Upside

As of 2024-05-20, the Relative Valuation of Dicerna Pharmaceuticals Inc (DRNA) is (49.44) USD. This relative valuation is based on P/E multiples. With the latest stock price at 38.22 USD, the upside of Dicerna Pharmaceuticals Inc based on Relative Valuation is -229.4%.

The range of the Relative Valuation is (49.81) - (47.24) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 30.3x - 36.9x 31.8x
Forward P/E multiples 25.9x - 28.8x 28.4x
Fair Price (49.81) - (47.24) (49.44)
Upside -230.3% - -223.6% -229.4%
38.22 USD
Stock Price
(49.44) USD
Fair Price

DRNA Relative Valuation - Historical P/E Data

Date P/E